Start free trial

Latest Disc Medicine News & Updates

See the latest news and media coverage for Disc Medicine. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Disc Medicine

Biopharmaceutical company developing hematology treatments

discmedicine.com
Headquarters
Watertown, United States
Company type
Public company
Number of employees
170–200
Industry
Pharmaceuticals

Last updated

Latest news about Disc Medicine

In short: Disc Medicine reported positive APOLLO results and completed a $422.4 million offering.

Company announcements

Disc Medicine

Disc Medicine presents RESTORE-PV trial results for DISC-3405 in PV patients at SOHO

Initial Phase 2 data shows reduced phlebotomy needs and improved symptoms. Company plans updates on DISC-3405 and selcodebart by year-end 2026.

Unlock all announcements with a

Media coverage

StreetInsider

Disc Medicine launches $350M public stock offering

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, announced a proposed underwritten public offering of $350 million in shares of common stock and pre-funded...

Endpoints News

Disc Medicine drug clears Phase 3 hurdles for EPP treatment

Bitopertin met all endpoints in the APOLLO trial, significantly increasing pain-free light hours and reducing PPIX levels compared to placebo.

Unlock all articles with a

Never miss news about Disc Medicine

Track Disc Medicine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Disc Medicine competitors & trending companies

Browse news for competitors to Disc Medicine and other trending companies.